WallStreetZenWallStreetZen

NYSE: TARO
Taro Pharmaceutical Industries Ltd Stock Ownership - Who owns Taro Pharmaceutical Industries?

Insider buying vs selling

Have Taro Pharmaceutical Industries Ltd insiders been buying or selling?
No trades
There has been no insiders buying vs selling in the past 12 months.

Be the first to know when TARO insiders and whales buy or sell their stock.

TARO Shareholders

What type of owners hold Taro Pharmaceutical Industries Ltd stock?
Institutional
Insider
Retail
NameHoldSharesValueType
Sun Pharmaceutical Industries Ltd50.73%19,066,860$805.77MInsider
Krensavage Asset Management LLC1.72%646,453$27.32MInstitution
Blackrock Inc1.66%622,983$26.33MInstitution
Renaissance Technologies LLC1.54%579,400$24.49MInstitution
Dimensional Fund Advisors LP1.45%545,682$23.06MInstitution
Brandes Investment Partners LP1.27%475,741$20.10MInstitution
Ameriprise Financial Inc0.82%307,225$12.98MInstitution
Eversept Partners LP0.68%255,988$10.82MInstitution
Invesco Ltd0.63%236,486$9.99MInstitution
Murchinson Ltd0.45%167,782$7.09MInstitution

1 of 3

TARO vs Pharmaceutical Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
TARO12.90%50.73%
DVAX71.63%28.37%Net SellingNet Selling
AVDL61.94%14.34%Net SellingNet Buying
ANIP21.93%78.07%Net SellingNet Selling
IRWD72.14%27.86%Net SellingNet Selling

Taro Pharmaceutical Industries Stock Ownership FAQ

Who owns Taro Pharmaceutical Industries?

Taro Pharmaceutical Industries (NYSE: TARO) is owned by 12.90% institutional shareholders, 50.73% Taro Pharmaceutical Industries insiders, and 36.37% retail investors. Sun Pharmaceutical Industries Ltd is the largest individual Taro Pharmaceutical Industries shareholder, owning 19.07M shares representing 50.73% of the company. Sun Pharmaceutical Industries Ltd's Taro Pharmaceutical Industries shares are currently valued at $807.29M.

If you're new to stock investing, here's how to buy Taro Pharmaceutical Industries stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.